Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN69942081Phase 4Completed
Phase 4, randomised, double-blind trial of tetanus and diphtheria toxoids adsorbed in Tetanus and diphtheria (2 arms), sponsored by Consellería de Sanidade. Primary endpoint: Increase in anti-tetanus antibody titer. Started Jan 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN69942081.